Early-Career Researcher Resource Center
Recent articles
News, perspectives and resources to help navigate the early stages of your neuroscience career
FEATURED PERSPECTIVES
Aging as adaptation: Learning the brain’s recipe for resilience
Reproducibility is a team sport: Lessons from a large-scale collaboration
FEATURED NEWS
The Transmitter ’s Rising Stars of Neuroscience 2025
How have funding cuts affected early-career scientists’ futures?
The Transmitter’s New Lab Directory
RESOURCES
Early-career researcher action potentials
Upcoming webinars
sensorimotor control, mouvement, touch, EEG
Decoding stress vulnerability
News and perspectives
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
The state of neuroscience in 2025: An overview
First Pan-African neuroscience journal gets ready to launch
Building the future of neuroscience at HBCUs
What U.S. science stands to lose without international graduate students and postdoctoral researchers
How to build a truly global computational neuroscience community
What kinds of support do early-career researchers need?
INSAR takes ‘intentional break’ from annual summer webinar series
On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.
On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.
Neuroscience needs to empower early-career researchers, not fund moon shots
Large-scale projects run the risk of stifling scientific independence. Instead, let’s explore alternative mechanisms of collaboration.
Neuroscience needs to empower early-career researchers, not fund moon shots
Large-scale projects run the risk of stifling scientific independence. Instead, let’s explore alternative mechanisms of collaboration.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
Federal funding cuts imperil next generation of autism researchers
As the International Society for Autism Research’s annual meeting begins, its next president reflects on a brewing crisis.
Federal funding cuts imperil next generation of autism researchers
As the International Society for Autism Research’s annual meeting begins, its next president reflects on a brewing crisis.
What birds can teach us about the ‘biological truth’ of sex
Part of our job as educators is to give students a deeper understanding of the true diversity of sex and gender in the natural world.
What birds can teach us about the ‘biological truth’ of sex
Part of our job as educators is to give students a deeper understanding of the true diversity of sex and gender in the natural world.
Explore more from The Transmitter
AI-assisted coding: 10 simple rules to maintain scientific rigor
These guidelines can help researchers ensure the integrity of their work while accelerating progress on important scientific questions.
AI-assisted coding: 10 simple rules to maintain scientific rigor
These guidelines can help researchers ensure the integrity of their work while accelerating progress on important scientific questions.
Glutamate receptors, mRNA transcripts and SYNGAP1; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 December.
Glutamate receptors, mRNA transcripts and SYNGAP1; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 December.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.